|
Volumn 1, Issue 1, 2011, Pages 1-
|
The era of cancer discovery
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE;
BCR ABL PROTEIN;
BIOLOGICAL MARKER;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
IMATINIB;
TRASTUZUMAB;
VEMURAFENIB;
BREAST CANCER;
CANCER RESEARCH;
CANCER THERAPY;
CHRONIC MYELOID LEUKEMIA;
COMBINATION CHEMOTHERAPY;
DNA SEQUENCE;
DRUG TREATMENT FAILURE;
EDITORIAL;
GENE MUTATION;
HUMAN;
LUNG CANCER;
MELANOMA;
MOLECULARLY TARGETED THERAPY;
NEOPLASM;
NONHUMAN;
ONCOGENE;
POSITRON EMISSION TOMOGRAPHY;
SOLID TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DISCOVERY;
DRUGS, INVESTIGATIONAL;
HUMANS;
INDIVIDUALITY;
INDIVIDUALIZED MEDICINE;
NEOPLASMS;
|
EID: 84862938941
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8274.CD-11-0049 Document Type: Editorial |
Times cited : (4)
|
References (0)
|